AAAAAA

   
Results: 1-9 |
Results: 9
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays
Authors: De Vos, J Couderc, G Tarte, K Jourdan, M Requirand, G Delteil, MC Rossi, JF Mechti, N Klein, B
Citation: J. De Vos et al., Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays, BLOOD, 98(3), 2001, pp. 771-780
Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro
Authors: Tarte, K Fiol, G Rossi, JF Klein, B
Citation: K. Tarte et al., Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro, LEUKEMIA, 14(12), 2000, pp. 2182-2192
JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells
Authors: De Vos, J Jourdan, M Tarte, K Jasmin, C Klein, B
Citation: J. De Vos et al., JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells, BR J HAEM, 109(4), 2000, pp. 823-828
Tumor necrosis factor is a survival and proliferation factor for human myeloma cells
Authors: Jourdan, M Tarte, K Legouffe, E Brochier, J Rossi, JF Klein, B
Citation: M. Jourdan et al., Tumor necrosis factor is a survival and proliferation factor for human myeloma cells, EUR CYTOKIN, 10(1), 1999, pp. 65-70
Dendritic cell-based vaccine: a promising approach for cancer immunotherapy
Authors: Tarte, K Klein, B
Citation: K. Tarte et B. Klein, Dendritic cell-based vaccine: a promising approach for cancer immunotherapy, LEUKEMIA, 13(5), 1999, pp. 653-663
Activation molecules on human myeloma cells
Authors: Klein, B Li, XY Lu, ZY Jourdan, M Tarte, K Brochier, J Claret, E Wijdenes, J Rossi, JF
Citation: B. Klein et al., Activation molecules on human myeloma cells, CURR T MICR, 246, 1999, pp. 335-341
Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells
Authors: Tarte, K Zhang, XG Legouffe, E Hertog, C Mehtali, M Rossi, JF Klein, B
Citation: K. Tarte et al., Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, J IMMUNOL, 163(1), 1999, pp. 514-524
Kaposi's sarcoma-associated herpesvirus and multiple myeloma: Lack of criteria for causality
Authors: Tarte, K Chang, Y Klein, B
Citation: K. Tarte et al., Kaposi's sarcoma-associated herpesvirus and multiple myeloma: Lack of criteria for causality, BLOOD, 93(10), 1999, pp. 3159-3163
Evidence against KSHV infection in the pathogenesis of multiple myeloma
Authors: Olsen, SJ Tarte, K Sherman, W Hale, EE Weisse, MT Orazi, A Klein, B Chang, Y
Citation: Sj. Olsen et al., Evidence against KSHV infection in the pathogenesis of multiple myeloma, VIRUS RES, 57(2), 1998, pp. 197-202
Risultati: 1-9 |